Fluoroquinolone Antibacterial [EPC]

Fluoroquinolone Antibacterial [EPC] was reported 129598 times

Drugs of the Fluoroquinolone Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONGENITAL HIATUS HERNIA 112 0.4912
1 SPIROMETRY ABNORMAL 276 0.4615
2 PULMONARY VASCULITIS 243 0.4517
3 MITE ALLERGY 270 0.4122
4 TENDON DISCOMFORT 311 0.4119
5 TOTAL LUNG CAPACITY ABNORMAL 150 0.3856
6 TENDON PAIN 2664 0.3515
7 VAGINAL FLATULENCE 96 0.3168
8 MYCOTIC ALLERGY 266 0.3111
9 DUST ALLERGY 283 0.2885
10 DYSBIOSIS 190 0.2314
11 TENDON DISORDER 1435 0.2199
12 CONJUNCTIVITIS ALLERGIC 296 0.1997
13 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 211 0.1987
14 CRYSTAL NEPHROPATHY 114 0.1926
15 SEDATION COMPLICATION 476 0.1864
16 NEPHROGENIC ANAEMIA 849 0.1831
17 TENDONITIS 2817 0.1818
18 HYPERPARATHYROIDISM SECONDARY 454 0.1810
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 131 0.1787
20 REBOUND ACID HYPERSECRETION 520 0.1717
21 NEURITIS 253 0.1638
22 SMALL FIBRE NEUROPATHY 117 0.1585
23 TENDON RUPTURE 1604 0.1298
24 JOINT NOISE 247 0.1256
25 CREATININE RENAL CLEARANCE DECREASED 492 0.1228
26 NASAL OEDEMA 215 0.1189
27 CHRONIC FATIGUE SYNDROME 165 0.1184
28 NORMOCHROMIC NORMOCYTIC ANAEMIA 334 0.1111
29 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 215 0.1053
30 JOINT CREPITATION 204 0.1028
31 TENDON INJURY 368 0.0988
32 PSEUDOMEMBRANOUS COLITIS 220 0.0984
33 VASCULAR PURPURA 135 0.0967
34 PATHOGEN RESISTANCE 878 0.0962
35 BLOODY DISCHARGE 108 0.0945
36 END STAGE RENAL DISEASE 1671 0.0915
37 RESPIRATORY SYMPTOM 259 0.0910
38 CONNECTIVE TISSUE DISORDER 125 0.0880
39 STENOTROPHOMONAS INFECTION 115 0.0847
40 EPICONDYLITIS 122 0.0808
41 FEMALE GENITAL TRACT FISTULA 138 0.0807
42 FUNGAEMIA 127 0.0806
43 FORCED EXPIRATORY VOLUME DECREASED 227 0.0800
44 CLOSTRIDIUM DIFFICILE COLITIS 749 0.0706
45 CHRONIC KIDNEY DISEASE 5325 0.0700
46 LINEAR IGA DISEASE 113 0.0679
47 MUSCLE RUPTURE 262 0.0672
48 INTERNATIONAL NORMALISED RATIO FLUCTUATION 139 0.0671
49 WEIGHT BEARING DIFFICULTY 179 0.0664
50 TUBULOINTERSTITIAL NEPHRITIS 1233 0.0657
51 CLOSTRIDIUM TEST POSITIVE 144 0.0652
52 CONTRAST MEDIA ALLERGY 119 0.0649
53 MEGACOLON 100 0.0636
54 FOOD INTOLERANCE 228 0.0622
55 TOXIC EPIDERMAL NECROLYSIS 945 0.0622
56 PULMONARY ALVEOLAR HAEMORRHAGE 349 0.0622
57 PLANTAR FASCIITIS 208 0.0620
58 NEUROLOGICAL SYMPTOM 350 0.0612
59 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1571 0.0610
60 FIXED ERUPTION 103 0.0598
61 TYPE I HYPERSENSITIVITY 208 0.0590
62 TORSADE DE POINTES 459 0.0584
63 HENOCH-SCHONLEIN PURPURA 127 0.0580
64 RADICULOPATHY 146 0.0553
65 CHRONIC SINUSITIS 205 0.0546
66 RENAL TUBULAR NECROSIS 532 0.0542
67 ENTEROCOCCAL INFECTION 261 0.0540
68 LONG QT SYNDROME 126 0.0525
69 PSEUDOMONAS INFECTION 448 0.0522
70 TENOSYNOVITIS 144 0.0522
71 PROSTATITIS 155 0.0509
72 KLEBSIELLA INFECTION 257 0.0508
73 PROCTITIS 142 0.0506
74 BLOOD CALCIUM DECREASED 567 0.0504
75 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 271 0.0497
76 MUSCLE CONTRACTIONS INVOLUNTARY 174 0.0494
77 ORTHOSTATIC HYPOTENSION 859 0.0493
78 MULTIPLE-DRUG RESISTANCE 152 0.0490
79 SYSTEMIC CANDIDA 123 0.0489
80 LUNG CONSOLIDATION 136 0.0486
81 FULL BLOOD COUNT ABNORMAL 514 0.0486
82 PNEUMONIA FUNGAL 190 0.0481
83 BRONCHIECTASIS 324 0.0480
84 CUTANEOUS VASCULITIS 174 0.0476
85 SPUTUM INCREASED 103 0.0476
86 LOSS OF EMPLOYMENT 143 0.0473
87 ASPERGILLUS INFECTION 308 0.0469
88 ARTERIOSCLEROSIS CORONARY ARTERY 309 0.0466
89 CHOLESTATIC LIVER INJURY 103 0.0462
90 HYPERACUSIS 172 0.0462
91 BRONCHOPULMONARY ASPERGILLOSIS 357 0.0460
92 RASH MORBILLIFORM 126 0.0454
93 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 353 0.0454
94 OBSTRUCTIVE AIRWAYS DISORDER 492 0.0442
95 MUCORMYCOSIS 113 0.0434
96 KOUNIS SYNDROME 98 0.0431
97 BREATH SOUNDS ABNORMAL 210 0.0425
98 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 211 0.0423
99 HEPATITIS CHOLESTATIC 254 0.0421
100 BENIGN PROSTATIC HYPERPLASIA 216 0.0418
101 DRUG RESISTANCE 1069 0.0416
102 MIXED LIVER INJURY 124 0.0412
103 ACUTE KIDNEY INJURY 6298 0.0411
104 VASCULITIS 472 0.0405
105 NOCARDIOSIS 103 0.0402
106 ARTERIOSCLEROSIS 376 0.0399
107 TOXIC ENCEPHALOPATHY 198 0.0390
108 PULMONARY PAIN 114 0.0390
109 MUSCLE ATROPHY 489 0.0386
110 CLOSTRIDIUM DIFFICILE INFECTION 834 0.0382
111 FEBRILE NEUTROPENIA 2530 0.0381
112 EOSINOPHILIA 661 0.0377
113 ATELECTASIS 363 0.0375
114 MYOCLONUS 445 0.0373
115 DERMATITIS EXFOLIATIVE GENERALISED 129 0.0371
116 RASH MACULO-PAPULAR 820 0.0368
117 RENAL INJURY 1091 0.0367
118 APLASTIC ANAEMIA 190 0.0363
119 CLOSTRIDIAL INFECTION 122 0.0360
120 ACUTE GRAFT VERSUS HOST DISEASE 165 0.0360
121 ANAL FISSURE 193 0.0359
122 DYSAESTHESIA 109 0.0355
123 OLIGURIA 220 0.0354
124 ANAL FISTULA 188 0.0352
125 EOSINOPHILIC PNEUMONIA 111 0.0352
126 BACTERAEMIA 413 0.0348
127 LIP OEDEMA 146 0.0344
128 ANAL ABSCESS 183 0.0339
129 STAPHYLOCOCCAL SEPSIS 167 0.0338
130 EXERCISE TOLERANCE DECREASED 194 0.0337
131 NEURALGIA 815 0.0335
132 VASCULAR DEVICE INFECTION 152 0.0335
133 AUTONOMIC NERVOUS SYSTEM IMBALANCE 97 0.0332
134 HEPATIC CYTOLYSIS 420 0.0329
135 DUODENITIS 101 0.0329
136 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 125 0.0327
137 ELECTROCARDIOGRAM QT PROLONGED 1177 0.0327
138 ESCHERICHIA URINARY TRACT INFECTION 139 0.0327
139 CYSTIC FIBROSIS 181 0.0327
140 CANDIDA INFECTION 548 0.0324
141 PARADOXICAL DRUG REACTION 119 0.0323
142 ESCHERICHIA INFECTION 266 0.0323
143 BACTERIAL SEPSIS 104 0.0319
144 RENAL FAILURE 4097 0.0308
145 NEUTROPENIC SEPSIS 220 0.0308
146 FISTULA 346 0.0307
147 CHOLESTASIS 589 0.0306
148 STEVENS-JOHNSON SYNDROME 681 0.0306
149 LYME DISEASE 102 0.0306
150 TOXIC SKIN ERUPTION 306 0.0304
151 ROTATOR CUFF SYNDROME 390 0.0303
152 SEPTIC SHOCK 1320 0.0303
153 POLYNEUROPATHY 361 0.0301
154 MUSCLE TWITCHING 694 0.0301
155 MUCOSAL INFLAMMATION 787 0.0300
156 CHOLECYSTITIS CHRONIC 201 0.0300
157 PYELONEPHRITIS 259 0.0299
158 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 97 0.0299
159 GRAFT VERSUS HOST DISEASE 213 0.0296
160 NERVE INJURY 329 0.0296
161 JAUNDICE CHOLESTATIC 104 0.0294
162 MULTIPLE ORGAN DYSFUNCTION SYNDROME 832 0.0293
163 ECONOMIC PROBLEM 444 0.0293
164 PURPURA 258 0.0291
165 NEUROPATHY PERIPHERAL 2765 0.0290
166 HYPERBILIRUBINAEMIA 300 0.0289
167 PERIPHERAL SENSORY NEUROPATHY 169 0.0289
168 DERMATITIS BULLOUS 208 0.0287
169 TINNITUS 1320 0.0287
170 LEUKOCYTOSIS 516 0.0285
171 ENDOPHTHALMITIS 168 0.0280
172 HYPOXIA 981 0.0278
173 STAPHYLOCOCCAL BACTERAEMIA 120 0.0276
174 BK VIRUS INFECTION 93 0.0275
175 IRON DEFICIENCY 124 0.0275
176 DRUG INTERACTION 4372 0.0275
177 WHEEZING 1619 0.0273
178 CYSTITIS HAEMORRHAGIC 110 0.0273
179 NODULE 351 0.0269
180 RESPIRATORY TRACT INFECTION 700 0.0268
181 DERMATITIS EXFOLIATIVE 134 0.0268
182 GUILLAIN-BARRE SYNDROME 128 0.0264
183 HALLUCINATIONS, MIXED 111 0.0264
184 DRUG-INDUCED LIVER INJURY 828 0.0264
185 CYTOKINE RELEASE SYNDROME 526 0.0262
186 CONJUNCTIVAL HYPERAEMIA 93 0.0261
187 NEUROTOXICITY 456 0.0260
188 TONGUE OEDEMA 99 0.0259
189 NEPHROPATHY 241 0.0258
190 ORAL CANDIDIASIS 338 0.0256
191 ENDOCARDITIS 131 0.0255
192 ENTERITIS 163 0.0254
193 INFLAMMATORY MARKER INCREASED 125 0.0252
194 NEPHROPATHY TOXIC 282 0.0251
195 SEDATION 654 0.0249
196 IMPAIRED WORK ABILITY 533 0.0249
197 VITREOUS FLOATERS 244 0.0248
198 PANCYTOPENIA 1387 0.0248
199 AGRANULOCYTOSIS 460 0.0247
200 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 254 0.0247
201 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 417 0.0245
202 ODYNOPHAGIA 146 0.0244
203 ABDOMINAL ABSCESS 108 0.0244
204 CANDIDIASIS 98 0.0244
205 MULTI-ORGAN FAILURE 421 0.0243
206 RENAL FUNCTION TEST ABNORMAL 113 0.0243
207 LYMPHOEDEMA 168 0.0243
208 HAEMODYNAMIC INSTABILITY 185 0.0243
209 LUNG INFILTRATION 214 0.0242
210 ANURIA 208 0.0241
211 NASAL POLYPS 119 0.0241
212 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 122 0.0241
213 ANHEDONIA 633 0.0241
214 SPUTUM DISCOLOURED 228 0.0240
215 RHINITIS ALLERGIC 107 0.0240
216 UROSEPSIS 221 0.0239
217 ABSCESS 381 0.0239
218 SUBCUTANEOUS ABSCESS 114 0.0238
219 AORTIC ANEURYSM 180 0.0236
220 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 177 0.0236
221 CYTOMEGALOVIRUS INFECTION REACTIVATION 104 0.0235
222 VENOOCCLUSIVE LIVER DISEASE 116 0.0235
223 BLOOD BILIRUBIN INCREASED 633 0.0234
224 DISSEMINATED INTRAVASCULAR COAGULATION 329 0.0233
225 OEDEMA 1261 0.0232
226 ACUTE RESPIRATORY DISTRESS SYNDROME 409 0.0231
227 HYPERURICAEMIA 95 0.0231
228 PANIC ATTACK 839 0.0230
229 PRODUCTIVE COUGH 1098 0.0230
230 FLANK PAIN 215 0.0229
231 PHOTOSENSITIVITY REACTION 377 0.0228
232 HAEMOPTYSIS 634 0.0227
233 DRUG LEVEL BELOW THERAPEUTIC 125 0.0226
234 HYPOALBUMINAEMIA 176 0.0226
235 HYPOMAGNESAEMIA 315 0.0226
236 INTERNATIONAL NORMALISED RATIO INCREASED 645 0.0226
237 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 199 0.0225
238 HYDROCEPHALUS 122 0.0224
239 HEPATIC ENCEPHALOPATHY 208 0.0223
240 C-REACTIVE PROTEIN INCREASED 811 0.0223
241 PURULENT DISCHARGE 95 0.0222
242 DEPRESSED LEVEL OF CONSCIOUSNESS 879 0.0222
243 ENTEROCOLITIS 128 0.0221
244 AFFECTIVE DISORDER 174 0.0221
245 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 131 0.0221
246 PROCTALGIA 142 0.0221
247 HEPATOTOXICITY 491 0.0220
248 PULMONARY FIBROSIS 422 0.0220
249 MYOPATHY 190 0.0220
250 STAPHYLOCOCCAL INFECTION 725 0.0220
251 MUSCLE FATIGUE 93 0.0219
252 ABDOMINAL TENDERNESS 109 0.0219
253 NECROSIS 122 0.0219
254 TENDERNESS 227 0.0218
255 PROTHROMBIN TIME PROLONGED 130 0.0217
256 HAEMOLYTIC ANAEMIA 194 0.0216
257 THROMBOCYTOPENIA 2418 0.0216
258 CHOLECYSTITIS ACUTE 122 0.0215
259 LIGAMENT RUPTURE 95 0.0215
260 WHEELCHAIR USER 95 0.0213
261 URINE ABNORMALITY 97 0.0213
262 DELIRIUM 740 0.0213
263 HYDRONEPHROSIS 159 0.0212
264 MUSCLE TIGHTNESS 344 0.0212
265 TACHYPNOEA 288 0.0212
266 ACUTE MYELOID LEUKAEMIA 330 0.0212
267 COGNITIVE DISORDER 988 0.0211
268 PHLEBITIS 108 0.0211
269 DEVICE RELATED INFECTION 324 0.0210
270 RENAL FAILURE ACUTE 893 0.0210
271 HYPOKALAEMIA 971 0.0210
272 CYTOMEGALOVIRUS INFECTION 347 0.0209
273 ENCEPHALOPATHY 511 0.0208
274 PNEUMONIA BACTERIAL 188 0.0205
275 PARAESTHESIA ORAL 295 0.0204
276 ACUTE HEPATIC FAILURE 279 0.0204
277 PETECHIAE 213 0.0204
278 RALES 118 0.0203
279 BACTERIAL INFECTION 378 0.0202
280 CACHEXIA 104 0.0202
281 FOOD ALLERGY 156 0.0202
282 MYALGIA 3435 0.0202
283 DRUG ERUPTION 356 0.0201
284 RESPIRATORY FAILURE 1461 0.0200
285 COLITIS 759 0.0200
286 SEPSIS 2232 0.0200
287 RHABDOMYOLYSIS 824 0.0197
288 MUSCULAR WEAKNESS 2239 0.0197
289 HYPERTRANSAMINASAEMIA 137 0.0197
290 ECCHYMOSIS 135 0.0197
291 APHTHOUS ULCER 151 0.0194
292 MUSCULOSKELETAL PAIN 1016 0.0194
293 CHOLANGITIS 120 0.0193
294 GROIN PAIN 169 0.0192
295 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 924 0.0192
296 ACUTE RESPIRATORY FAILURE 370 0.0192
297 PNEUMOCYSTIS JIROVECII PNEUMONIA 193 0.0192
298 CYSTITIS 610 0.0191
299 QUALITY OF LIFE DECREASED 256 0.0191
300 LEUKOPENIA 950 0.0190
301 ERYTHEMA MULTIFORME 177 0.0190
302 MYOSITIS 170 0.0189
303 INTESTINAL ISCHAEMIA 104 0.0189
304 NERVOUS SYSTEM DISORDER 588 0.0188
305 PHOTOPHOBIA 353 0.0187
306 COAGULOPATHY 312 0.0187
307 DIVERTICULUM 133 0.0187
308 RENAL CYST 148 0.0186
309 BLOOD PRESSURE DIASTOLIC DECREASED 137 0.0185
310 DRUG LEVEL INCREASED 307 0.0185
311 DIVERTICULITIS 513 0.0185
312 STATUS EPILEPTICUS 209 0.0185
313 ELECTROLYTE IMBALANCE 215 0.0185
314 HEPATITIS ACUTE 120 0.0184
315 BLOOD ALKALINE PHOSPHATASE INCREASED 458 0.0184
316 JAUNDICE 496 0.0184
317 VARICOSE VEIN 95 0.0184
318 GINGIVITIS 99 0.0183
319 SPINAL OSTEOARTHRITIS 161 0.0183
320 BLOOD LACTATE DEHYDROGENASE INCREASED 290 0.0183
321 BURSITIS 222 0.0183
322 MICTURITION URGENCY 209 0.0183
323 HEPATOCELLULAR INJURY 259 0.0182
324 MALNUTRITION 204 0.0182
325 SENSORY DISTURBANCE 292 0.0182
326 VENTRICULAR TACHYCARDIA 300 0.0181
327 INTRACRANIAL PRESSURE INCREASED 101 0.0181
328 PARAESTHESIA 2847 0.0181
329 METABOLIC DISORDER 105 0.0181
330 RESPIRATORY DISTRESS 497 0.0180
331 TUMOUR LYSIS SYNDROME 158 0.0179
332 NEUTROPHIL COUNT INCREASED 183 0.0179
333 METABOLIC ACIDOSIS 571 0.0178
334 MITRAL VALVE INCOMPETENCE 202 0.0178
335 URINE OUTPUT DECREASED 156 0.0178
336 SINUS TACHYCARDIA 253 0.0178
337 NEUTROPENIA 2415 0.0177
338 PNEUMOTHORAX 280 0.0176
339 BURNING SENSATION 1235 0.0176
340 FORMICATION 122 0.0175
341 TRANSAMINASES INCREASED 389 0.0175
342 HAEMATURIA 598 0.0174
343 VENTRICULAR FIBRILLATION 193 0.0174
344 CYTOPENIA 212 0.0173
345 PNEUMONITIS 470 0.0172
346 PYREXIA 5958 0.0172
347 HEPATIC STEATOSIS 320 0.0172
348 COVID-19 PNEUMONIA 201 0.0170
349 GASTROOESOPHAGEAL REFLUX DISEASE 1370 0.0170
350 GASTROINTESTINAL PAIN 187 0.0170
351 WALKING AID USER 112 0.0170
352 ASPARTATE AMINOTRANSFERASE INCREASED 902 0.0170
353 PERIPHERAL COLDNESS 233 0.0170
354 GAMMA-GLUTAMYLTRANSFERASE INCREASED 376 0.0169
355 OESOPHAGITIS 185 0.0169
356 PNEUMONIA 5476 0.0169
357 ALANINE AMINOTRANSFERASE INCREASED 1035 0.0168
358 RENAL IMPAIRMENT 1416 0.0168
359 FACE OEDEMA 284 0.0168
360 DECUBITUS ULCER 137 0.0168
361 EXTRASYSTOLES 117 0.0167
362 VENTRICULAR EXTRASYSTOLES 174 0.0167
363 BLOOD CREATININE INCREASED 1093 0.0167
364 MEDICATION ERROR 929 0.0167
365 BLOOD UREA INCREASED 279 0.0166
366 GENERALISED TONIC-CLONIC SEIZURE 275 0.0166
367 DRUG LEVEL DECREASED 169 0.0166
368 BLOOD ALBUMIN DECREASED 131 0.0165
369 SKIN WARM 96 0.0165
370 LEFT VENTRICULAR DYSFUNCTION 110 0.0164
371 MOUTH ULCERATION 346 0.0164
372 NEUTROPHIL COUNT DECREASED 669 0.0164
373 HYPOVOLAEMIA 96 0.0164
374 PLEURAL EFFUSION 990 0.0163
375 MENTAL STATUS CHANGES 451 0.0162
376 HIATUS HERNIA 210 0.0162
377 THROMBOTIC MICROANGIOPATHY 158 0.0162
378 DYSURIA 593 0.0161
379 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 153 0.0160
380 OSTEOMYELITIS 290 0.0160
381 OSTEOPENIA 243 0.0160
382 HEPATIC FAILURE 481 0.0159
383 MUSCLE STRAIN 138 0.0159
384 CIRCULATORY COLLAPSE 271 0.0159
385 JOINT STIFFNESS 417 0.0159
386 BALANCE DISORDER 1372 0.0159
387 HAEMATOMA 411 0.0158
388 GENERALISED OEDEMA 196 0.0158
389 LYMPHOCYTE COUNT DECREASED 279 0.0158
390 LUNG INFECTION 245 0.0158
391 CARDIAC FAILURE ACUTE 105 0.0157
392 MUSCULOSKELETAL DISCOMFORT 271 0.0157
393 HYPERCHOLESTEROLAEMIA 152 0.0157
394 MENINGITIS 105 0.0157
395 PAIN IN EXTREMITY 4623 0.0157
396 HAEMOLYSIS 121 0.0157
397 GASTROINTESTINAL INFECTION 140 0.0156
398 MUSCLE DISORDER 126 0.0155
399 URINARY TRACT INFECTION 2650 0.0155
400 HALLUCINATION, VISUAL 328 0.0155
401 PAROSMIA 117 0.0155
402 MOBILITY DECREASED 1113 0.0155
403 TRICUSPID VALVE INCOMPETENCE 123 0.0155
404 HYPONATRAEMIA 872 0.0155
405 PSYCHOTIC DISORDER 457 0.0155
406 ASTHMA 1748 0.0154
407 MENISCUS INJURY 95 0.0154
408 HEPATITIS 395 0.0154
409 MULTIPLE ALLERGIES 121 0.0154
410 ATRIAL FLUTTER 123 0.0154
411 TACHYCARDIA 1368 0.0154
412 HYPOTHYROIDISM 491 0.0154
413 RED BLOOD CELL SEDIMENTATION RATE INCREASED 170 0.0153
414 GASTROENTERITIS 224 0.0153
415 ANAEMIA 2918 0.0153
416 HAEMODIALYSIS 128 0.0152
417 PULMONARY MASS 227 0.0152
418 HYPOGAMMAGLOBULINAEMIA 100 0.0152
419 EPSTEIN-BARR VIRUS INFECTION 95 0.0152
420 FIBROMYALGIA 368 0.0151
421 IMPAIRED QUALITY OF LIFE 217 0.0151
422 PULMONARY HAEMORRHAGE 118 0.0151
423 LYMPHOPENIA 213 0.0150
424 JOINT DISLOCATION 159 0.0150
425 EAR PAIN 292 0.0150
426 ANXIETY 4249 0.0149
427 HAEMATOCRIT DECREASED 296 0.0149
428 ARTHRALGIA 6206 0.0149
429 BLOOD PRESSURE SYSTOLIC INCREASED 291 0.0149
430 HYPOAESTHESIA 2231 0.0149
431 DYSPNOEA EXERTIONAL 560 0.0149
432 MUSCULOSKELETAL CHEST PAIN 230 0.0148
433 CARDIOMEGALY 182 0.0148
434 HAEMATOTOXICITY 140 0.0147
435 BODY TEMPERATURE DECREASED 145 0.0147
436 PULMONARY TOXICITY 104 0.0147
437 DIARRHOEA HAEMORRHAGIC 137 0.0146
438 ABNORMAL FAECES 120 0.0146
439 LUNG DISORDER 717 0.0146
440 BRAIN FOG 229 0.0146
441 NIGHT SWEATS 469 0.0145
442 LARGE INTESTINE PERFORATION 101 0.0145
443 ABNORMAL LOSS OF WEIGHT 99 0.0145
444 SUPRAVENTRICULAR TACHYCARDIA 139 0.0145
445 SHOCK HAEMORRHAGIC 118 0.0145
446 CHOLECYSTITIS 171 0.0143
447 RENAL PAIN 152 0.0143
448 SPINAL PAIN 168 0.0143
449 SMALL INTESTINAL OBSTRUCTION 176 0.0143
450 SWOLLEN TONGUE 445 0.0142
451 TEMPERATURE INTOLERANCE 147 0.0142
452 DISORIENTATION 564 0.0142
453 COLITIS ISCHAEMIC 96 0.0142
454 CARDIAC MURMUR 123 0.0142
455 SECRETION DISCHARGE 178 0.0142
456 SPLENOMEGALY 166 0.0142
457 EOSINOPHIL COUNT INCREASED 118 0.0141
458 SCHIZOPHRENIA 172 0.0141
459 HEPATOMEGALY 139 0.0141
460 UPPER RESPIRATORY TRACT INFECTION 653 0.0141
461 EYELID OEDEMA 164 0.0141
462 RESTLESSNESS 516 0.0141
463 URINARY RETENTION 470 0.0141
464 ILEUS 175 0.0141
465 HYPOPHOSPHATAEMIA 104 0.0141
466 DISTURBANCE IN ATTENTION 758 0.0140
467 BRAIN OEDEMA 177 0.0140
468 HYPERAESTHESIA 115 0.0140
469 CELLULITIS 704 0.0140
470 ARRHYTHMIA 661 0.0139
471 FUNGAL INFECTION 465 0.0139
472 SKIN LESION 382 0.0139
473 MYASTHENIA GRAVIS 112 0.0139
474 HYPOGLYCAEMIA 671 0.0138
475 HYPOTONIA 138 0.0138
476 AUTOIMMUNE HEPATITIS 96 0.0138
477 HYPOCALCAEMIA 261 0.0138
478 JOINT EFFUSION 95 0.0138
479 NECK PAIN 769 0.0137
480 ATAXIA 163 0.0137
481 GAIT INABILITY 459 0.0137
482 RASH PUSTULAR 100 0.0137
483 HYPERKALAEMIA 481 0.0137
484 KIDNEY INFECTION 269 0.0137
485 PHARYNGITIS 170 0.0137
486 INFLAMMATION 705 0.0136
487 PULMONARY EMBOLISM 1296 0.0136
488 BONE MARROW FAILURE 276 0.0136
489 SHOCK 310 0.0135
490 POST PROCEDURAL INFECTION 109 0.0134
491 HICCUPS 110 0.0134
492 HOSPICE CARE 132 0.0134
493 CONFUSIONAL STATE 2156 0.0133
494 ANGIOEDEMA 590 0.0133
495 OBESITY 212 0.0133
496 HALLUCINATION 1002 0.0133
497 GASTROINTESTINAL INFLAMMATION 104 0.0133
498 HYPOTENSION 2647 0.0132
499 WHITE BLOOD CELL COUNT INCREASED 506 0.0132
500 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 937 0.0132
501 GAIT DISTURBANCE 2519 0.0131
502 WOUND INFECTION 144 0.0131
503 LOWER RESPIRATORY TRACT INFECTION 597 0.0131
504 PLATELET COUNT DECREASED 1399 0.0131
505 JOINT INJURY 279 0.0130
506 EAR DISCOMFORT 134 0.0130
507 RHINITIS 105 0.0130
508 LIVER FUNCTION TEST ABNORMAL 377 0.0130
509 FREQUENT BOWEL MOVEMENTS 350 0.0129
510 ABDOMINAL PAIN 3014 0.0129
511 APHASIA 391 0.0129
512 DYSSTASIA 378 0.0129
513 SLEEP DISORDER 913 0.0129
514 PARALYSIS 185 0.0129
515 HALLUCINATION, AUDITORY 205 0.0129
516 CHOLELITHIASIS 423 0.0129
517 BODY TEMPERATURE INCREASED 263 0.0129
518 RENAL FAILURE CHRONIC 99 0.0129
519 RESPIRATORY RATE INCREASED 114 0.0128
520 ANAPHYLACTIC REACTION 709 0.0128
521 LYMPHADENOPATHY 454 0.0128
522 PALPITATIONS 1500 0.0128
523 SUBARACHNOID HAEMORRHAGE 130 0.0128
524 UPPER GASTROINTESTINAL HAEMORRHAGE 214 0.0127
525 ABASIA 314 0.0127
526 CONTRAINDICATED PRODUCT ADMINISTERED 384 0.0127
527 PNEUMONIA ASPIRATION 316 0.0126
528 EMPHYSEMA 127 0.0126
529 POLYURIA 103 0.0126
530 HEART RATE IRREGULAR 284 0.0126
531 ANAL INCONTINENCE 113 0.0125
532 PERICARDIAL EFFUSION 290 0.0125
533 GASTRITIS 330 0.0125
534 INFECTION 1812 0.0125
535 HEPATIC FUNCTION ABNORMAL 466 0.0125
536 INTERSTITIAL LUNG DISEASE 604 0.0125
537 SENSORY LOSS 100 0.0124
538 BEDRIDDEN 163 0.0124
539 BLOOD MAGNESIUM DECREASED 107 0.0124
540 ALTERED STATE OF CONSCIOUSNESS 268 0.0124
541 PANCREATITIS ACUTE 277 0.0123
542 DEAFNESS 322 0.0123
543 LIVER INJURY 302 0.0123
544 CONDITION AGGRAVATED 3738 0.0123
545 CHROMATURIA 277 0.0123
546 PHARYNGEAL SWELLING 120 0.0123
547 ABDOMINAL PAIN LOWER 310 0.0122
548 VAGINAL DISCHARGE 124 0.0122
549 LIMB DISCOMFORT 379 0.0122
550 JOINT RANGE OF MOTION DECREASED 164 0.0122
551 PLATELET COUNT INCREASED 158 0.0121
552 ASCITES 356 0.0121
553 MUSCULOSKELETAL STIFFNESS 1057 0.0121
554 PARANOIA 208 0.0121
555 INTESTINAL PERFORATION 135 0.0120
556 EPILEPSY 367 0.0120
557 NIGHTMARE 414 0.0120
558 ATRIAL FIBRILLATION 1163 0.0119
559 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 623 0.0119
560 ABORTION SPONTANEOUS 478 0.0119
561 INTERVERTEBRAL DISC DEGENERATION 110 0.0119
562 UVEITIS 161 0.0119
563 HAEMOGLOBIN DECREASED 1212 0.0118
564 RASH ERYTHEMATOUS 564 0.0118
565 DECREASED ACTIVITY 127 0.0118
566 SINUS CONGESTION 159 0.0118
567 JOINT SWELLING 1417 0.0117
568 BLOOD SODIUM DECREASED 221 0.0117
569 MELAENA 258 0.0117
570 IRON DEFICIENCY ANAEMIA 108 0.0117
571 DEPRESSION 2660 0.0117
572 SINUS BRADYCARDIA 113 0.0117
573 BLADDER DISORDER 116 0.0117
574 PULMONARY CONGESTION 154 0.0117
575 BLOOD COUNT ABNORMAL 177 0.0117
576 DRUG INTOLERANCE 1124 0.0116
577 HAEMATOCHEZIA 641 0.0116
578 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 636 0.0116
579 SKIN INFECTION 130 0.0116
580 OEDEMA PERIPHERAL 1410 0.0116
581 GASTROINTESTINAL DISORDER 1036 0.0116
582 BRONCHITIS 854 0.0115
583 ACTIVITIES OF DAILY LIVING IMPAIRED 228 0.0115
584 RESPIRATORY DISORDER 344 0.0115
585 ADVERSE REACTION 152 0.0115
586 SEROTONIN SYNDROME 220 0.0114
587 IRRITABLE BOWEL SYNDROME 245 0.0114
588 SKIN ULCER 295 0.0114
589 MUSCULOSKELETAL DISORDER 217 0.0114
590 FACIAL PARALYSIS 97 0.0114
591 CONSTIPATION 2479 0.0114
592 BLOOD POTASSIUM DECREASED 341 0.0113
593 DYSPHAGIA 1076 0.0113
594 MANIA 186 0.0113
595 HYPERLIPIDAEMIA 135 0.0113
596 INFUSION SITE ERYTHEMA 95 0.0113
597 OSTEOARTHRITIS 477 0.0112
598 WHITE BLOOD CELL COUNT DECREASED 1218 0.0112
599 MUSCLE INJURY 93 0.0112
600 EMBOLISM 93 0.0112
601 TRANSFUSION 117 0.0112
602 SLEEP APNOEA SYNDROME 213 0.0111
603 DYSPNOEA 6313 0.0111
604 GENERAL PHYSICAL HEALTH DETERIORATION 1288 0.0111
605 FAECES DISCOLOURED 241 0.0111
606 DEHYDRATION 1476 0.0111
607 ASTHENIA 4160 0.0111
608 MACULAR DEGENERATION 132 0.0110
609 LOCALISED INFECTION 267 0.0110
610 DENTAL CARIES 122 0.0110
611 PSYCHOLOGICAL TRAUMA 95 0.0110
612 BRONCHOSPASM 157 0.0110
613 DYSPHONIA 643 0.0110
614 PROTEINURIA 208 0.0109
615 HAEMORRHOIDS 213 0.0109
616 LIVER DISORDER 484 0.0109
617 RECTAL HAEMORRHAGE 467 0.0109
618 VITAMIN D DEFICIENCY 106 0.0109
619 FACIAL PAIN 97 0.0109
620 COORDINATION ABNORMAL 151 0.0108
621 HEART RATE DECREASED 379 0.0108
622 BLOOD PRESSURE FLUCTUATION 259 0.0108
623 URINARY INCONTINENCE 318 0.0107
624 DERMATITIS ALLERGIC 135 0.0107
625 VOMITING 5045 0.0107
626 DRUG TOXICITY 146 0.0107
627 BACK PAIN 2490 0.0107
628 ADRENAL INSUFFICIENCY 130 0.0107
629 MUSCLE RIGIDITY 128 0.0107
630 PRESYNCOPE 260 0.0107
631 THROAT TIGHTNESS 289 0.0107
632 NEPHROLITHIASIS 490 0.0107
633 ORAL PAIN 239 0.0107
634 HYPERGLYCAEMIA 388 0.0106
635 INSOMNIA 2836 0.0106
636 MYELODYSPLASTIC SYNDROME 154 0.0106
637 TREATMENT FAILURE 881 0.0106
638 PAIN IN JAW 300 0.0106
639 GALLBLADDER DISORDER 189 0.0106
640 OPTIC NEURITIS 96 0.0106
641 PAIN 6463 0.0105
642 EXOSTOSIS 96 0.0105
643 TOXICITY TO VARIOUS AGENTS 1771 0.0105
644 COUGH 2945 0.0105
645 DYSPEPSIA 1033 0.0105
646 TREMOR 1737 0.0105
647 SPINAL DISORDER 99 0.0104
648 ARTHROPATHY 581 0.0104
649 AGITATION 766 0.0104
650 DECREASED APPETITE 2419 0.0104
651 BLISTER 584 0.0104
652 MUSCLE SPASMS 1907 0.0104
653 RED BLOOD CELL COUNT DECREASED 297 0.0104
654 DEEP VEIN THROMBOSIS 674 0.0104
655 SWELLING FACE 675 0.0104
656 BLOOD CREATINE PHOSPHOKINASE INCREASED 298 0.0103
657 SUBDURAL HAEMATOMA 148 0.0103
658 HYPOPHAGIA 264 0.0103
659 CHEST PAIN 1912 0.0103
660 GOUT 185 0.0103
661 MOTOR DYSFUNCTION 105 0.0103
662 SWELLING 964 0.0103
663 CHILLS 1207 0.0103
664 LIP SWELLING 342 0.0103
665 OSTEOPOROSIS 421 0.0102
666 HYPERCALCAEMIA 126 0.0102
667 OXYGEN SATURATION DECREASED 573 0.0102
668 INJURY 716 0.0102
669 BLOOD URINE PRESENT 193 0.0102
670 MENTAL IMPAIRMENT 246 0.0101
671 SUDDEN DEATH 107 0.0101
672 DIARRHOEA 6521 0.0101
673 LACTIC ACIDOSIS 326 0.0101
674 CARDIAC ARREST 831 0.0101
675 IMPAIRED GASTRIC EMPTYING 137 0.0100
676 VISUAL ACUITY REDUCED 333 0.0100
677 TOOTH INFECTION 132 0.0100
678 PULMONARY OEDEMA 448 0.0100
679 EYE PAIN 564 0.0100
680 MENTAL DISORDER 435 0.0100
681 FLUID OVERLOAD 145 0.0100
682 POOR VENOUS ACCESS 103 0.0099
683 CARPAL TUNNEL SYNDROME 139 0.0099
684 BONE DISORDER 180 0.0099
685 FULL BLOOD COUNT DECREASED 199 0.0099
686 CORONARY ARTERY DISEASE 299 0.0099
687 RIB FRACTURE 203 0.0099
688 MASS 137 0.0098
689 DIPLOPIA 254 0.0098
690 MOVEMENT DISORDER 314 0.0098
691 HEAD DISCOMFORT 173 0.0098
692 CYANOSIS 153 0.0097
693 NOCTURIA 118 0.0097
694 IMMUNE SYSTEM DISORDER 128 0.0097
695 STOMATITIS 589 0.0097
696 RASH PRURITIC 526 0.0097
697 CONJUNCTIVITIS 180 0.0097
698 HEMIPARESIS 163 0.0096
699 PERITONITIS 199 0.0096
700 CARDIOMYOPATHY 142 0.0096
701 BONE PAIN 562 0.0096
702 SYNCOPE 959 0.0096
703 VISUAL IMPAIRMENT 1187 0.0096
704 HEART RATE INCREASED 948 0.0096
705 DYSARTHRIA 360 0.0096
706 HAEMATEMESIS 242 0.0095
707 INTERVERTEBRAL DISC PROTRUSION 208 0.0095
708 LIGAMENT SPRAIN 94 0.0095
709 THROMBOSIS 763 0.0095
710 DECREASED IMMUNE RESPONSIVENESS 93 0.0095
711 TASTE DISORDER 192 0.0095
712 INCONTINENCE 100 0.0095
713 ASPIRATION 103 0.0094
714 HAEMORRHAGE INTRACRANIAL 140 0.0094
715 HEPATIC ENZYME INCREASED 638 0.0093
716 DISEASE PROGRESSION 1105 0.0093
717 CARDIAC FAILURE 749 0.0093
718 URTICARIA 1562 0.0093
719 SARS-COV-2 TEST POSITIVE 123 0.0093
720 WEIGHT DECREASED 2599 0.0093
721 DISABILITY 184 0.0093
722 CARDIOVASCULAR DISORDER 236 0.0093
723 RASH 4047 0.0093
724 RASH GENERALISED 239 0.0092
725 CHEST DISCOMFORT 945 0.0092
726 TOOTHACHE 167 0.0092
727 PRURITUS GENERALISED 199 0.0092
728 PELVIC PAIN 167 0.0092
729 COLD SWEAT 162 0.0092
730 PULMONARY HYPERTENSION 190 0.0091
731 RASH PAPULAR 204 0.0091
732 INFUSION RELATED REACTION 603 0.0091
733 HYPERSENSITIVITY 1688 0.0091
734 SEIZURE 1046 0.0090
735 HEPATIC CIRRHOSIS 170 0.0090
736 FEAR 243 0.0090
737 VERTIGO 550 0.0090
738 ERYTHEMA 1854 0.0090
739 EAR INFECTION 240 0.0090
740 THINKING ABNORMAL 168 0.0090
741 EJECTION FRACTION DECREASED 140 0.0090
742 INTRAOCULAR PRESSURE INCREASED 115 0.0090
743 ULCER 143 0.0090
744 FATIGUE 6955 0.0089
745 FEELING COLD 248 0.0089
746 SEASONAL ALLERGY 126 0.0089
747 ABDOMINAL PAIN UPPER 1828 0.0089
748 RENAL DISORDER 413 0.0089
749 DERMATITIS 185 0.0088
750 POLLAKIURIA 368 0.0088
751 LETHARGY 507 0.0088
752 ARTHRITIS 693 0.0088
753 DYSKINESIA 357 0.0088
754 HYPERTENSION 1859 0.0088
755 PERIPHERAL SWELLING 1349 0.0087
756 NAUSEA 6918 0.0087
757 POOR QUALITY SLEEP 188 0.0087
758 HYPERHIDROSIS 1123 0.0087
759 SINUSITIS 891 0.0087
760 BRADYCARDIA 459 0.0086
761 GASTROINTESTINAL HAEMORRHAGE 720 0.0086
762 SUICIDAL IDEATION 785 0.0086
763 ORAL HERPES 167 0.0085
764 CARDIOGENIC SHOCK 122 0.0085
765 EYE INFECTION 96 0.0085
766 UNRESPONSIVE TO STIMULI 219 0.0085
767 FOOT DEFORMITY 94 0.0085
768 SCAR 145 0.0085
769 DELUSION 131 0.0084
770 ABDOMINAL DISTENSION 878 0.0084
771 VISION BLURRED 1153 0.0084
772 IMPAIRED DRIVING ABILITY 95 0.0083
773 WOUND 233 0.0083
774 OROPHARYNGEAL PAIN 771 0.0083
775 MALAISE 3649 0.0083
776 PSYCHOMOTOR HYPERACTIVITY 138 0.0083
777 PALLOR 226 0.0083
778 EMOTIONAL DISTRESS 1005 0.0083
779 SKIN REACTION 116 0.0082
780 DEPRESSED MOOD 434 0.0082
781 ABDOMINAL DISCOMFORT 1376 0.0082
782 CARDIO-RESPIRATORY ARREST 343 0.0082
783 EPISTAXIS 613 0.0082
784 IMPAIRED HEALING 269 0.0082
785 DIALYSIS 116 0.0082
786 BONE DENSITY DECREASED 256 0.0082
787 BLOOD PRESSURE DECREASED 542 0.0081
788 CEREBRAL HAEMORRHAGE 292 0.0081
789 DRY EYE 407 0.0081
790 MIDDLE INSOMNIA 152 0.0081
791 EXTRAPYRAMIDAL DISORDER 202 0.0081
792 CARDIAC FAILURE CONGESTIVE 652 0.0081
793 PRODUCT PRESCRIBING ISSUE 176 0.0081
794 HERPES ZOSTER 464 0.0081
795 RASH MACULAR 281 0.0080
796 PHARYNGEAL OEDEMA 123 0.0080
797 INTENTIONAL PRODUCT USE ISSUE 699 0.0080
798 RESTLESS LEGS SYNDROME 145 0.0080
799 BLOOD POTASSIUM INCREASED 129 0.0079
800 GASTROENTERITIS VIRAL 143 0.0079
801 RESPIRATORY DEPRESSION 97 0.0079
802 DIZZINESS 3933 0.0079
803 EATING DISORDER 167 0.0078
804 ANAPHYLACTIC SHOCK 202 0.0078
805 FOOT FRACTURE 148 0.0078
806 APHONIA 108 0.0077
807 TRANSIENT ISCHAEMIC ATTACK 261 0.0077
808 PRODUCT PRESCRIBING ERROR 184 0.0077
809 COLITIS ULCERATIVE 345 0.0077
810 BLOOD TEST ABNORMAL 108 0.0077
811 CONTUSION 737 0.0076
812 OFF LABEL USE 6701 0.0076
813 HYPOKINESIA 111 0.0076
814 AMNESIA 497 0.0076
815 LIVER FUNCTION TEST INCREASED 164 0.0076
816 METASTASES TO BONE 125 0.0076
817 SKIN DISORDER 254 0.0076
818 ACUTE MYOCARDIAL INFARCTION 223 0.0076
819 FALL 2495 0.0075
820 ORAL DISCOMFORT 104 0.0075
821 DISEASE RECURRENCE 355 0.0075
822 THIRST 133 0.0074
823 PRODUCT USE IN UNAPPROVED INDICATION 1833 0.0074
824 ANGINA PECTORIS 211 0.0074
825 THERAPY NON-RESPONDER 331 0.0074
826 VIRAL INFECTION 245 0.0074
827 LOCAL SWELLING 127 0.0073
828 INTESTINAL OBSTRUCTION 274 0.0073
829 PLASMA CELL MYELOMA 283 0.0072
830 SKIN EXFOLIATION 609 0.0072
831 PROCEDURAL PAIN 200 0.0072
832 IMMUNODEFICIENCY 107 0.0072
833 LABORATORY TEST ABNORMAL 211 0.0071
834 GASTRIC DISORDER 245 0.0071
835 APATHY 104 0.0071
836 LOSS OF CONSCIOUSNESS 903 0.0070
837 PRURITUS 2706 0.0070
838 LIMB INJURY 191 0.0070
839 SINUS DISORDER 138 0.0070
840 DRY MOUTH 565 0.0070
841 GINGIVAL BLEEDING 95 0.0070
842 BLOOD PRESSURE ABNORMAL 138 0.0069
843 MEMORY IMPAIRMENT 953 0.0069
844 AGEUSIA 173 0.0069
845 SPEECH DISORDER 362 0.0069
846 HEADACHE 4298 0.0068
847 ANKLE FRACTURE 106 0.0068
848 TOOTH LOSS 141 0.0068
849 SCIATICA 108 0.0068
850 THERAPEUTIC PRODUCT EFFECT DECREASED 303 0.0068
851 FLATULENCE 383 0.0067
852 FLUID RETENTION 343 0.0067
853 DYSGEUSIA 500 0.0067
854 BLOOD PRESSURE INCREASED 1028 0.0067
855 GASTRIC ULCER 127 0.0067
856 HYPOACUSIS 287 0.0067
857 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 155 0.0066
858 FEELING HOT 406 0.0066
859 NASAL CONGESTION 388 0.0066
860 CATARACT 392 0.0066
861 POST PROCEDURAL COMPLICATION 126 0.0066
862 CONVULSION 374 0.0065
863 EYE SWELLING 243 0.0065
864 INFLUENZA 727 0.0065
865 OSTEONECROSIS OF JAW 161 0.0065
866 SKIN DISCOLOURATION 297 0.0065
867 MIGRAINE 610 0.0064
868 PANCREATITIS 337 0.0064
869 RESPIRATORY TRACT CONGESTION 100 0.0063
870 THYROID DISORDER 97 0.0063
871 FEEDING DISORDER 126 0.0062
872 HYPOAESTHESIA ORAL 93 0.0062
873 BLOOD TRIGLYCERIDES INCREASED 109 0.0062
874 FEELING ABNORMAL 1467 0.0061
875 EYE DISORDER 201 0.0061
876 CEREBRAL INFARCTION 149 0.0061
877 RESPIRATORY ARREST 168 0.0061
878 NEOPLASM PROGRESSION 211 0.0061
879 ALOPECIA 1188 0.0060
880 NERVOUSNESS 316 0.0060
881 DEMENTIA 169 0.0060
882 RHINORRHOEA 390 0.0060
883 MYELOSUPPRESSION 217 0.0060
884 PERICARDITIS 101 0.0060
885 SYNOVITIS 108 0.0060
886 DISCOMFORT 364 0.0060
887 COMA 284 0.0060
888 RETCHING 126 0.0059
889 EMOTIONAL DISORDER 180 0.0058
890 ABNORMAL DREAMS 161 0.0058
891 SOMNOLENCE 1172 0.0058
892 DIABETES MELLITUS INADEQUATE CONTROL 103 0.0058
893 UPPER LIMB FRACTURE 115 0.0058
894 HAEMORRHAGE 603 0.0058
895 DIABETES MELLITUS 437 0.0057
896 COVID-19 1005 0.0057
897 HIP FRACTURE 183 0.0057
898 CRYING 204 0.0056
899 TREATMENT NONCOMPLIANCE 307 0.0056
900 NASOPHARYNGITIS 1025 0.0056
901 GLOSSODYNIA 124 0.0055
902 METASTASES TO LIVER 97 0.0055
903 KNEE ARTHROPLASTY 113 0.0054
904 SNEEZING 120 0.0053
905 PAIN OF SKIN 142 0.0053
906 ILLNESS 543 0.0053
907 TYPE 2 DIABETES MELLITUS 177 0.0053
908 DRUG INEFFECTIVE 6919 0.0052
909 OCULAR HYPERAEMIA 249 0.0052
910 MOOD ALTERED 143 0.0052
911 SPINAL FRACTURE 103 0.0051
912 HYPERSOMNIA 147 0.0051
913 HERNIA 98 0.0051
914 DYSTONIA 98 0.0050
915 EXPOSURE DURING PREGNANCY 312 0.0050
916 ADVERSE DRUG REACTION 449 0.0050
917 THROAT IRRITATION 224 0.0050
918 HOT FLUSH 374 0.0050
919 SYSTEMIC LUPUS ERYTHEMATOSUS 176 0.0050
920 ECZEMA 259 0.0049
921 TOOTH DISORDER 110 0.0049
922 LACRIMATION INCREASED 149 0.0049
923 OSTEONECROSIS 161 0.0049
924 GLAUCOMA 94 0.0049
925 BLINDNESS 197 0.0048
926 MOOD SWINGS 154 0.0048
927 WEIGHT INCREASED 1081 0.0048
928 AGGRESSION 240 0.0048
929 PRODUCT USE ISSUE 887 0.0047
930 CARDIAC DISORDER 438 0.0047
931 MALIGNANT NEOPLASM PROGRESSION 479 0.0047
932 ERECTILE DYSFUNCTION 120 0.0047
933 UNEVALUABLE EVENT 348 0.0046
934 ABNORMAL BEHAVIOUR 182 0.0046
935 HOSPITALISATION 697 0.0045
936 INFLUENZA LIKE ILLNESS 372 0.0045
937 RHEUMATOID ARTHRITIS 493 0.0043
938 BLOOD CHOLESTEROL INCREASED 201 0.0043
939 ILL-DEFINED DISORDER 260 0.0043
940 THERAPY CESSATION 216 0.0042
941 HEAD INJURY 133 0.0042
942 PREMATURE BABY 126 0.0042
943 LUNG NEOPLASM MALIGNANT 170 0.0041
944 FLUSHING 419 0.0041
945 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 721 0.0040
946 SKIN BURNING SENSATION 286 0.0040
947 TARDIVE DYSKINESIA 112 0.0040
948 PRODUCT DOSE OMISSION 245 0.0037
949 FEMUR FRACTURE 115 0.0037
950 DRUG ABUSE 309 0.0037
951 DEATH 3138 0.0036
952 INTENTIONAL PRODUCT MISUSE 317 0.0036
953 EYE IRRITATION 206 0.0036
954 MYOCARDIAL INFARCTION 613 0.0035
955 EYE PRURITUS 118 0.0035
956 IRRITABILITY 210 0.0035
957 ROAD TRAFFIC ACCIDENT 146 0.0035
958 OVERDOSE 743 0.0034
959 DRY SKIN 456 0.0034
960 VAGINAL HAEMORRHAGE 145 0.0033
961 SURGERY 193 0.0033
962 INTENTIONAL DOSE OMISSION 93 0.0033
963 PSORIATIC ARTHROPATHY 129 0.0032
964 ANGER 106 0.0031
965 THERAPEUTIC RESPONSE SHORTENED 102 0.0031
966 THERAPY INTERRUPTED 217 0.0030
967 PRODUCT DOSE OMISSION ISSUE 889 0.0030
968 ADVERSE EVENT 275 0.0030
969 BLOOD GLUCOSE DECREASED 143 0.0030
970 SUICIDE ATTEMPT 180 0.0030
971 FOETAL EXPOSURE DURING PREGNANCY 241 0.0030
972 CEREBROVASCULAR ACCIDENT 489 0.0029
973 PSORIASIS 365 0.0028
974 NEOPLASM MALIGNANT 177 0.0026
975 MATERNAL EXPOSURE DURING PREGNANCY 233 0.0026
976 BLOOD GLUCOSE INCREASED 492 0.0026
977 THERAPEUTIC RESPONSE DECREASED 153 0.0025
978 COMPLETED SUICIDE 210 0.0025
979 INCORRECT DOSE ADMINISTERED 538 0.0024
980 ACNE 155 0.0020
981 MULTIPLE SCLEROSIS RELAPSE 136 0.0020
982 UNDERDOSE 141 0.0019
983 INTENTIONAL OVERDOSE 119 0.0019
984 DRUG DOSE OMISSION 303 0.0018
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 119 0.0017
986 INJECTION SITE PRURITUS 98 0.0015
987 NO ADVERSE EVENT 252 0.0014
988 PROSTATE CANCER 109 0.0014
989 DRUG WITHDRAWAL SYNDROME 115 0.0013
990 INJECTION SITE ERYTHEMA 152 0.0012
991 INJECTION SITE SWELLING 93 0.0012
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 243 0.0012
993 DRUG DEPENDENCE 185 0.0011
994 INJECTION SITE PAIN 328 0.0011
995 PRODUCT QUALITY ISSUE 133 0.0010